Deep PIM kinase substrate profiling reveals new rational co-therapeutic strategies for acute myeloid leukemia.
Joglekar T, Chin A, Voskanian-Kordi A, Seungchul B, Raja A, Rege A, Huang W, Kane MA, Laiho M, Webb T, Fan X, Rubenstein M, Bieberich CJ, Li X.
Joglekar T, et al. Among authors: huang w.
Blood Adv. 2024 May 13:bloodadvances.2022008144. doi: 10.1182/bloodadvances.2022008144. Online ahead of print.
Blood Adv. 2024.
PMID: 38739710